跳至主要内容
临床试验/ACTRN12611000182998
ACTRN12611000182998进行中(未招募)2 期

A double blind randomized clinical trial to evaluate the effect of oral allopurinol on the prevention of post ERCP pancreatitis

Mohammad Abbasinazari0 个研究点目标入组 500 人开始时间: 2011年2月15日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
20 Years 至 70 Years(—)
性别
All

入选标准

  • all patients above 20 years old undergoing ERCP in the gastrointestinal and liver diseases ward of Talighani hospital (Tehran, Iran) with informed consent

排除标准

  • patients with renal failure or patients with bone marrow suppression ,those who had developed acute pancreatitis during 2 weeks before ERCP, pregnant women, patient who took azathioprine and those who didn’t agree to participate in the study.

研究者

发起方
Mohammad Abbasinazari

相似试验